Biote Reiterates Guidance
Portfolio Pulse from Benzinga Newsdesk
Biote has reaffirmed its 2024 financial guidance, citing a strong first quarter and expectations for increased revenue growth in the latter half of the year. The company expects revenues to be between $200-$204 million and adjusted EBITDA to be in the range of $60-$63 million.
May 07, 2024 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biote reaffirms its 2024 financial guidance with expected revenues of $200-$204 million and adjusted EBITDA of $60-$63 million, indicating a positive outlook based on Q1 performance and future growth expectations.
Reaffirming financial guidance, especially with specific revenue and EBITDA targets, typically instills confidence in investors about the company's future performance and stability. Given the positive outlook based on solid Q1 performance and anticipated growth, this news is likely to have a positive short-term impact on Biote's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100